Povidone-iodine topical antiseptic recalled nationwide for subpotent active ingredient
Medline Industries is recalling 2,680 bottles of READYPREP PVP povidone-iodine 10% topical antiseptic solution due to subpotency. The affected product may not provide adequate antiseptic effectiveness.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III voluntary recall with no reported illnesses or injuries. The defect is subpotency—insufficient active ingredient—a quality issue rather than contamination or addition of a harmful substance. The hazard is theoretical, fitting the rubric criteria for 'voluntary precautionary recalls' at the Moderate severity level.
Plain-English summary
Medline Industries, LP is recalling READYPREP PVP Povidone-Iodine 10% Solution, a topical antiseptic product. The recall involves 2,680 bottles in 1-gallon sizes with lot number 24EJA180 and an expiration date of June 1, 2027.
The product was recalled because it is subpotent—containing insufficient active ingredient to ensure the intended antiseptic effectiveness. This is a voluntary recall initiated by Medline Industries.
The affected product was distributed nationwide in the United States. Consumers who have this product should discontinue use and consult their healthcare provider if they have questions about the recall or need advice regarding alternative antiseptic options.
The recalled product
- Product
- POVIDONE-IODINE (POVIDONE-IODINE)
- Brand
- POVIDONE-IODINE
- Manufacturer
- Medline Industries, LP
- Category
- Drug — Topical Antiseptic
- Hazard
- sub-potency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 24EJA180
- Exp 06/01/2027
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27